Risk-Based Validation
How to validate smarter, not harder: applying risk assessment to reduce validation burden while maintaining compliance
1. The Problem with Traditional Validation
Traditional Computer System Validation (CSV) treated all systems equally: every system got the same exhaustive validation regardless of actual risk. This led to massive validation backlogs, years-long timelines, and validation teams becoming bottlenecks rather than enablers.
Traditional CSV Pain Points:
- 6-12 month validation cycles for simple systems
- Hundreds of test cases for low-risk applications
- Re-validation nightmares for minor changes
- Validation documents longer than the code itself
- Compliance theater instead of real quality
2. Risk-Based Validation Philosophy
Risk-based validation focuses effort where it matters most. The principle is simple:
"The level of validation effort should be proportional to the risk the system poses to patient safety, product quality, and data integrity."
This approach is endorsed by FDA (in multiple guidance documents) and formalized in GAMP 5 (Good Automated Manufacturing Practice).
2.1 Risk Assessment Framework
Patient Safety
Could a system failure harm a patient?
High risk = extensive testing of safety-critical functions
Product Quality
Could a malfunction affect product efficacy?
High risk = detailed IQ/OQ/PQ for manufacturing systems
Data Integrity
Does the system create/store GxP records?
High risk = audit trail testing, ALCOA+ verification
Regulatory Visibility
Will this data be submitted to FDA?
High visibility = stricter validation documentation
System Complexity
Custom code vs. COTS? Integrations?
Complex = more testing; simple COTS = lighter validation
3. GAMP 5 Categories
GAMP 5 categorizes systems by complexity, with validation effort scaling accordingly:
Category 1
Infrastructure
OS, databases, hardware
Supplier assessment only
Category 3
Non-Configured
COTS used as-is (Excel, Word)
Supplier + light IQ/OQ
Category 4
Configured
COTS + config (VDC system)
Full IQ/OQ/PQ
Category 5
Custom
Fully custom software
SDLC + extensive testing
4. VDC System Risk Assessment
Let''s apply risk-based thinking to the VDC system:
VDC System Risk Profile
Patient Safety Impact:LowDocument approval system doesn''t directly affect patient treatment
Product Quality Impact:LowDoesn''t control manufacturing or testing processes
Data Integrity Risk:HighCreates and maintains GxP records requiring audit trail
GAMP Category:Category 4AWS managed services + configuration + custom Lambda
4.1 Validation Strategy
Based on this risk profile, the VDC validation focused on:
High Priority Testing
- Audit trail completeness and immutability
- Access control and role separation
- Document integrity (hash verification)
- MFA enforcement
- ALCOA+ data integrity principles
Medium Priority Testing
- End-to-end workflows
- Error handling
- Performance benchmarks
- AWS infrastructure configuration
Lower Priority Testing
- UI cosmetic elements
- Non-GxP features (help text, tooltips)
- Edge cases with minimal real-world impact
5. Practical Risk-Based Decisions
5.1 Testing Scope Decisions
Document approval workflow
High
Full PQ testing with multiple scenarios
Audit trail creation
High
OQ + PQ tests for every action type
SHA-256 hash calculation
High
Detailed OQ test with manual verification
Login page styling
Low
Visual inspection, no formal test case
Help text content
Low
Review only, no testing required
5.2 Change Control Decisions
Risk-based validation also applies to changes:
Scenario: Update Lambda function to add new approval reason field
Risk: Medium (adds data field, doesn''t change core logic)
Action: Targeted OQ tests for new field + smoke test existing workflows. No full re-validation.
Scenario: Change DynamoDB audit table schema
Risk: High (affects data integrity and audit trail)
Action: Full impact assessment + re-execute relevant OQ/PQ tests + update validation docs.
Scenario: Update button text from "Submit" to "Submit for Review"
Risk: Low (UI text only, no functional change)
Action: Change control documentation only. No testing required.
6. Benefits of Risk-Based Validation
⚡
Faster Time to Production
Focus effort on critical areas = faster validation cycles. VDC validated in 4 days, not 4 months.
💰
Lower Cost
Fewer unnecessary tests = less validation overhead. Spend budget where it matters.
🎯
Better Quality
Deep testing on high-risk areas finds real issues. Shallow testing everywhere finds nothing.
📈
Scalable
Sustainable validation approach that doesn''t collapse under system growth.
7. Common Objections
"But FDA expects comprehensive validation!"
FDA guidance explicitly endorses risk-based approaches. FDA inspectors look for appropriate validation, not checkbox compliance. Document your risk assessment and be prepared to justify decisions.
"What if we miss something critical?"
Risk assessment is systematic, not arbitrary. If you properly identify high-risk areas (patient safety, data integrity), you won''t miss critical items. Traditional validation misses things too - it just takes longer.
"Our QA team will never approve this."
Educate stakeholders on GAMP 5 and FDA guidance. Show the math: risk-based validation actually deliversbetter coverage of critical areas. Quality teams want systems that work, not validation documents.